About the Company
passage bio, inc., a genetic medicines company, develops transformative therapies for rare monogenic central nervous system (cns) diseases. the company develops pbgm01, which utilizes a proprietary, aavhu68 capsid to deliver to the brain and peripheral tissues a functional glb1 gene encoding lysosomal acid beta-galactosidase (ã-gal) for infantile gm1; pbft02, which utilizes an aav1 capsid to deliver to the brain a functional granulin, or grn, gene encoding progranulin for the treatment of ftd caused by a deficiency of progranulin; and pbkr03, which utilizes a proprietary, aavhu68 capsid to deliver to the brain and peripheral tissues a functional galc gene encoding the hydrolytic enzyme galactosylceramidase, for infantile krabbe disease. it has a strategic research collaboration with the trustees of the university of pennsylvania's gene therapy program; and collaboration agreement, and a development services and clinical supply agreement with catalent maryland, inc. the company was fou
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $PASG News
Passage Bio, Inc. (PASG) Is Up 24.26% in One Week: What You Should Know
Debate surrounding which are the best and worst metrics to focus on is lengthy, but the Zacks Momentum Style Score, part of the Zacks Style Scores, helps address this issue for us.Below, we take a ...
Passage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business Highlights
Continued momentum in upliFT-D trial of PBFT02 for the treatment of patients with frontotemporal dementia (FTD) with granulin mutations (GRN) ...
Passage Bio Seeks Pennsylvania College Student Candidates for Third Annual Tachi Yamada Scholarship Program
The official rules and application details are available on Passage Bio’s website in the Careers section at Passage Bio, Inc. – Careers. Applications must be submitted by April 26, 2024 and will be ...
Weight Loss Drugs Threatened by US Effort to Contain China
Popular weight loss and diabetes drugs are getting caught up in a bid by US lawmakers to reduce the country’s reliance on ...
WuXi AppTec, WuXi Bio Tumble After US Panel Advances Ban Bill
WuXi AppTec Co. tumbled after a US Senate committee advanced a bill that may ban Chinese biotech firms from accessing federal ...
Voyager Therapeutics: A Tortoise With A Shot At Making Gene Therapy Deliver Easier
Voyager Therapeutics investors need to be patient as the biotech targets hard to treat Alzheimer's and Parkinson's. Read why ...
Independent Contractor Rule Takes Effect, But Legal Challenges Mount
You are responsible for reading, understanding and agreeing to the National Law Review's (NLR’s) and the National Law Forum ...
AnaptysBio Inc.
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
National Pi Day 2024: Get a deal whether you prefer apple, cherry or pizza pie
Pi Day is Thursday, March 14, and Blaze Pizza, Papa John's and others have pizza deals. Specials on pie and Taco Bell's ...
Q4 2023 Aemetis Inc Earnings Call
Todd Waltz; EVP & CFO; Aemetis, Inc. Eric McAfee; Chairman of the Board ... And this year, we generated revenue from the sale of LCFS credits from our aim at US Bio gas operations for the first time ...
Loading the latest forecasts...